Switzerland: Noema Pharma extends Series B financing round

Noema Pharma, a clinical-stage biotech company targeting central nervous system (CNS) disorders, has closed a Series B extension financing round with an investment from...

UK: Kester Capital backs management team in acquiring EMAS Pharma

UK private equity investor, Kester Capital, has announced its acquisition, alongside an experienced incoming executive team, of CRO EMAS Pharma, the clinical development division of Bionical...

The Netherlands: GPW Group acquires Orly Pharma

Germany-based pharmaceutical distributor GPW Group, with the support of its majority shareholder Silver Investment Partners (SIP), has acquired the Dutch-German pharmaceutical wholesaler Orly Pharma. The...

UK: Lorena Cosmetics Holdings SPV acquires and re-launches the sk:n and The Harley Medical...

Lorena Cosmetics Holdings SPV, a healthcare services company operating as part of the UK-based Lorena Investments Group, has acquired and re-launched the sk:n and...

Germany: Sonic Healthcare acquires LADR laboratory group

ASX-listed Sonic Healthcare has agreed to acquire LADR – Laboratory Group Dr Kramer & Colleagues – a medical laboratory group in Germany. LADR is...

France: Lauxera announces first close of Growth II at €300m

Lauxera Capital Partners has announced the first close of Lauxera Growth II at €300m (US$316m), representing 75% of the target and already exceeding the...

Spain: Ampersand makes growth investment in VIVEbiotech

VIVEbiotech, a lentiviral vector CDMO, has receive growth equity investment from life sciences and healthcare investor Ampersand Capital Partners. The partnership will help expand...

UK: Triton Debt Opportunities Fund III surpasses €1bn

Triton Debt Opportunities (TDO), the opportunistic credit arm of European investment firm Triton, has announced the final close of its third fund in excess...

Czech Republic: Novavax to sell Czech Republic manufacturing site to Novo Nordisk for US$200m

US-based Nasdaq-listed Novavax, a company advancing protein-based vaccines, has agreed to sell its manufacturing facility in Bohumil, Czech Republic to Novo Nordisk for US$200m. The agreement includes...

Germany: ISP Healthcare and VINC join forces to create new European healthcare and life...

Healthcare advisors, Germany-based ISP HEALTHCARE GmbH and Austria-based VINC - Healthcare Advisory, have joined forces under the ISP umbrella, creating a new powerhouse in...
Advertisement